2.4.1.9 Html 151 271 1 true 49 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.endocyte.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 102 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.endocyte.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.endocyte.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Sheet http://www.endocyte.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) false false R5.htm 105 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) Sheet http://www.endocyte.com/role/ConsolidatedStatementsOfStockholdersEquityDeficit CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) false false R6.htm 106 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.endocyte.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R7.htm 107 - Disclosure - Nature of Business and Organization Sheet http://www.endocyte.com/role/NatureOfBusinessAndOrganization Nature of Business and Organization false false R8.htm 108 - Disclosure - Significant Accounting Policies Sheet http://www.endocyte.com/role/SignificantAccountingPolicies Significant Accounting Policies false false R9.htm 109 - Disclosure - New Accounting Pronouncements Sheet http://www.endocyte.com/role/NewAccountingPronouncements New Accounting Pronouncements false false R10.htm 110 - Disclosure - Net Income (Loss) Per Share Sheet http://www.endocyte.com/role/NetIncomeLossPerShare Net Income (Loss) Per Share false false R11.htm 111 - Disclosure - Other Comprehensive Income (Loss) Sheet http://www.endocyte.com/role/OtherComprehensiveIncomeLoss Other Comprehensive Income (Loss) false false R12.htm 112 - Disclosure - Investments Sheet http://www.endocyte.com/role/Investments Investments false false R13.htm 113 - Disclosure - Property and Equipment Sheet http://www.endocyte.com/role/PropertyAndEquipment Property and Equipment false false R14.htm 114 - Disclosure - Long-Term Debt Sheet http://www.endocyte.com/role/LongtermDebt Long-Term Debt false false R15.htm 115 - Disclosure - Warrants Sheet http://www.endocyte.com/role/Warrants Warrants false false R16.htm 116 - Disclosure - Leases Sheet http://www.endocyte.com/role/Leases Leases false false R17.htm 117 - Disclosure - Stockholders' Equity (Deficit) Sheet http://www.endocyte.com/role/StockholdersEquityDeficit Stockholders' Equity (Deficit) false false R18.htm 118 - Disclosure - Income Taxes Sheet http://www.endocyte.com/role/IncomeTaxes Income Taxes false false R19.htm 119 - Disclosure - Collaborations Sheet http://www.endocyte.com/role/Collaborations Collaborations false false R20.htm 120 - Disclosure - Related-Party Transactions Sheet http://www.endocyte.com/role/RelatedpartyTransactions Related-Party Transactions false false R21.htm 121 - Disclosure - Retirement Plans Sheet http://www.endocyte.com/role/RetirementPlans Retirement Plans false false R22.htm 122 - Disclosure - Commitments and Contingencies Sheet http://www.endocyte.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R23.htm 123 - Disclosure - Restructuring Costs Sheet http://www.endocyte.com/role/RestructuringCosts Restructuring Costs false false R24.htm 124 - Disclosure - Selected Quarterly Financial Data (unaudited) Sheet http://www.endocyte.com/role/SelectedQuarterlyFinancialDataUnaudited Selected Quarterly Financial Data (unaudited) false false R25.htm 125 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.endocyte.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) false false R26.htm 126 - Disclosure - Net Income (Loss) Per Share (Tables) Sheet http://www.endocyte.com/role/NetIncomeLossPerShareTables Net Income (Loss) Per Share (Tables) false false R27.htm 127 - Disclosure - Other Comprehensive Income (Loss) (Tables) Sheet http://www.endocyte.com/role/OtherComprehensiveIncomeLossTables Other Comprehensive Income (Loss) (Tables) false false R28.htm 128 - Disclosure - Investments (Tables) Sheet http://www.endocyte.com/role/InvestmentsTables Investments (Tables) false false R29.htm 129 - Disclosure - Property and Equipment (Tables) Sheet http://www.endocyte.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) false false R30.htm 130 - Disclosure - Leases (Tables) Sheet http://www.endocyte.com/role/LeasesTables Leases (Tables) false false R31.htm 131 - Disclosure - Stockholders' Equity (Deficit) (Tables) Sheet http://www.endocyte.com/role/StockholdersEquityDeficitTables Stockholders' Equity (Deficit) (Tables) false false R32.htm 132 - Disclosure - Income Taxes (Tables) Sheet http://www.endocyte.com/role/IncomeTaxesTables Income Taxes (Tables) false false R33.htm 133 - Disclosure - Restructuring Costs (Tables) Sheet http://www.endocyte.com/role/RestructuringCostsTables Restructuring Costs (Tables) false false R34.htm 134 - Disclosure - Selected Quarterly Financial Data (unaudited) (Tables) Sheet http://www.endocyte.com/role/SelectedQuarterlyFinancialDataUnauditedTables Selected Quarterly Financial Data (unaudited) (Tables) false false R35.htm 135 - Disclosure - Nature of Business and Organization (Details Textual) Sheet http://www.endocyte.com/role/NatureOfBusinessAndOrganizationDetailsTextual Nature of Business and Organization (Details Textual) false false R36.htm 136 - Disclosure - Significant Accounting Policies (Details Textual) Sheet http://www.endocyte.com/role/SignificantAccountingPoliciesDetailsTextual Significant Accounting Policies (Details Textual) false false R37.htm 137 - Disclosure - Net Income (Loss) Per Share (Details) Sheet http://www.endocyte.com/role/NetIncomeLossPerShareDetails Net Income (Loss) Per Share (Details) false false R38.htm 138 - Disclosure - Net Income (Loss) Per Share (Details 1) Sheet http://www.endocyte.com/role/NetIncomeLossPerShareDetails1 Net Income (Loss) Per Share (Details 1) false false R39.htm 139 - Disclosure - Other Comprehensive Income (Loss) (Details) Sheet http://www.endocyte.com/role/OtherComprehensiveIncomeLossDetails Other Comprehensive Income (Loss) (Details) false false R40.htm 140 - Disclosure - Other Comprehensive Income (Loss) (Details 1) Sheet http://www.endocyte.com/role/OtherComprehensiveIncomeLossDetails1 Other Comprehensive Income (Loss) (Details 1) false false R41.htm 141 - Disclosure - Investments (Details) Sheet http://www.endocyte.com/role/InvestmentsDetails Investments (Details) false false R42.htm 142 - Disclosure - Investments (Details Textual) Sheet http://www.endocyte.com/role/InvestmentsDetailsTextual Investments (Details Textual) false false R43.htm 143 - Disclosure - Property and Equipment (Details) Sheet http://www.endocyte.com/role/PropertyAndEquipmentDetails Property and Equipment (Details) false false R44.htm 144 - Disclosure - Property and Equipment (Details Textual) Sheet http://www.endocyte.com/role/PropertyAndEquipmentDetailsTextual Property and Equipment (Details Textual) false false R45.htm 145 - Disclosure - Long-Term Debt (Details Textual) Sheet http://www.endocyte.com/role/LongtermDebtDetailsTextual Long-Term Debt (Details Textual) false false R46.htm 146 - Disclosure - Warrants (Details Textual) Sheet http://www.endocyte.com/role/WarrantsDetailsTextual Warrants (Details Textual) false false R47.htm 147 - Disclosure - Leases (Details) Sheet http://www.endocyte.com/role/LeasesDetails Leases (Details) false false R48.htm 148 - Disclosure - Leases (Details Textual) Sheet http://www.endocyte.com/role/LeasesDetailsTextual Leases (Details Textual) false false R49.htm 149 - Disclosure - Stockholders' Equity (Deficit) (Details) Sheet http://www.endocyte.com/role/StockholdersEquityDeficitDetails Stockholders' Equity (Deficit) (Details) false false R50.htm 150 - Disclosure - Stockholders' Equity (Deficit) (Details 1) Sheet http://www.endocyte.com/role/StockholdersEquityDeficitDetails1 Stockholders' Equity (Deficit) (Details 1) false false R51.htm 151 - Disclosure - Stockholders' Equity (Deficit) (Details 2) Sheet http://www.endocyte.com/role/StockholdersEquityDeficitDetails2 Stockholders' Equity (Deficit) (Details 2) false false R52.htm 152 - Disclosure - Stockholders' Equity (Deficit) (Details Textual) Sheet http://www.endocyte.com/role/StockholdersEquityDeficitDetailsTextual Stockholders' Equity (Deficit) (Details Textual) false false R53.htm 153 - Disclosure - Income Taxes (Details) Sheet http://www.endocyte.com/role/IncomeTaxesDetails Income Taxes (Details) false false R54.htm 154 - Disclosure - Income Taxes (Details 1) Sheet http://www.endocyte.com/role/IncomeTaxesDetails1 Income Taxes (Details 1) false false R55.htm 155 - Disclosure - Income Taxes (Details Textual) Sheet http://www.endocyte.com/role/IncomeTaxesDetailsTextual Income Taxes (Details Textual) false false R56.htm 156 - Disclosure - Collaborations (Details Textual) Sheet http://www.endocyte.com/role/CollaborationsDetailsTextual Collaborations (Details Textual) false false R57.htm 157 - Disclosure - Related-Party Transactions (Details Textual) Sheet http://www.endocyte.com/role/RelatedpartyTransactionsDetailsTextual Related-Party Transactions (Details Textual) false false R58.htm 158 - Disclosure - Retirement Plans (Details Textual) Sheet http://www.endocyte.com/role/RetirementPlansDetailsTextual Retirement Plans (Details Textual) false false R59.htm 159 - Disclosure - Restructuring Costs (Details) Sheet http://www.endocyte.com/role/RestructuringCostsDetails Restructuring Costs (Details) false false R60.htm 160 - Disclosure - Restructuring Costs (Details Textual) Sheet http://www.endocyte.com/role/RestructuringCostsDetailsTextual Restructuring Costs (Details Textual) false false R61.htm 161 - Disclosure - Selected Quarterly Financial Data (unaudited) (Details) Sheet http://www.endocyte.com/role/SelectedQuarterlyFinancialDataUnauditedDetails Selected Quarterly Financial Data (unaudited) (Details) false false All Reports Book All Reports Element ecyt_EffectiveIncomeTaxRateReconciliationOrphanDrugCreditsPercent had a mix of decimals attribute values: 0 3. Element us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate had a mix of decimals attribute values: 0 3. Element us-gaap_PrepaidExpenseCurrent had a mix of decimals attribute values: -5 0. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 28 values. Shorter duration columns must have at least one fourth (7) as many values. Column '1/1/2013 - 3/31/2013' is shorter (89 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 28 values. Shorter duration columns must have at least one fourth (7) as many values. Column '4/1/2013 - 6/30/2013' is shorter (90 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 28 values. Shorter duration columns must have at least one fourth (7) as many values. Column '7/1/2013 - 9/30/2013' is shorter (91 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 28 values. Shorter duration columns must have at least one fourth (7) as many values. Column '10/1/2013 - 12/31/2013' is shorter (91 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 28 values. Shorter duration columns must have at least one fourth (7) as many values. Column '1/1/2014 - 3/31/2014' is shorter (89 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 28 values. Shorter duration columns must have at least one fourth (7) as many values. Column '4/1/2014 - 6/30/2014' is shorter (90 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 28 values. Shorter duration columns must have at least one fourth (7) as many values. Column '7/1/2014 - 9/30/2014' is shorter (91 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 28 values. Shorter duration columns must have at least one fourth (7) as many values. Column '10/1/2014 - 12/31/2014' is shorter (91 days) and has only 2 values, so it is being removed. 'Monetary' elements on report '156 - Disclosure - Collaborations (Details Textual)' had a mix of different decimal attribute values. Process Flow-Through: 102 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 103 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 104 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Process Flow-Through: Removing column '1 Months Ended Jul. 31, 2014' Process Flow-Through: Removing column '1 Months Ended Feb. 28, 2011' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: 106 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS ecyt-20141231.xml ecyt-20141231.xsd ecyt-20141231_cal.xml ecyt-20141231_def.xml ecyt-20141231_lab.xml ecyt-20141231_pre.xml true true